Evaluation of 2′-deoxy-2′-[18F]fluoro-5-methyl-1-β-l-arabinofuranosyluracil ([18F]-l-FMAU) as a PET imaging agent for cellular proliferation: comparison with [18F]-d-FMAU and [18F]FLT

[1]  W. Bornmann,et al.  Radiosynthesis of 2'-deoxy-2'-[18F]-fluoro-5-methyl-1-beta-L-arabinofuranosyluracil ([18F]-L-FMAU) for PET. , 2007, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

[2]  J. Ajani,et al.  Early Detection of Chemoradioresponse in Esophageal Carcinoma by 3′-Deoxy-3′-3H-Fluorothymidine Using Preclinical Tumor Models , 2006, Clinical Cancer Research.

[3]  H. Yoo,et al.  Rapid Quantitative Determination of L-FMAU-TP from Human Peripheral-Blood Mononuclear Cells of Hepatitis B Virus-Infected Patients Treated with L-FMAU by Ion-Pairing, Reverse-Phase, Liquid Chromatography/Electrospray Tandem Mass Spectrometry , 2006, Therapeutic drug monitoring.

[4]  S. Shousha,et al.  Quantification of cellular proliferation in tumor and normal tissues of patients with breast cancer by [18F]fluorothymidine-positron emission tomography imaging: evaluation of analytical methods. , 2005, Cancer research.

[5]  Otto Muzik,et al.  A simplified analysis of [18F]3′-deoxy-3′-fluorothymidine metabolism and retention , 2005, European Journal of Nuclear Medicine and Molecular Imaging.

[6]  B. Degrève,et al.  Behavior of Thymidylate Kinase toward Monophosphate Metabolites and Its Role in the Metabolism of 1-(2′-Deoxy-2′-Fluoro-β-l-Arabinofuranosyl)-5-Methyluracil (Clevudine) and 2′,3′-Didehydro-2′,3′-Dideoxythymidine in Cells , 2005, Antimicrobial Agents and Chemotherapy.

[7]  J. Bading,et al.  Pharmacokinetics of the thymidine analog 2'-fluoro-5-methyl-1-beta-D-arabinofuranosyluracil (FMAU) in tumor-bearing rats. , 2004, Nuclear medicine and biology.

[8]  Joanne Wang,et al.  (Section A: Molecular, Structural, and Cellular Biology of Drug Transporters) Mammalian Nucleoside Transporters , 2004 .

[9]  G. Peters,et al.  Expression of deoxycytidine kinase in leukaemic cells compared with solid tumour cell lines, liver metastases and normal liver. , 2003, European journal of cancer.

[10]  C. K. Chu,et al.  Understanding the unique mechanism of L-FMAU (clevudine) against hepatitis B virus: molecular dynamics studies. , 2002, Bioorganic & medicinal chemistry letters.

[11]  P. Conti,et al.  Synthesis of [18F]‐labeled 2′‐deoxy‐2′‐fluoro‐5‐methyl‐1‐β‐D‐arabinofuranosyluracil ([18F]‐FMAU) , 2002 .

[12]  Wing Lam,et al.  Phosphorylation of Pyrimidine Deoxynucleoside Analog Diphosphates , 2002, The Journal of Biological Chemistry.

[13]  M. Andreeff,et al.  Phase II study of troxacitabine, a novel dioxolane nucleoside analog, in patients with refractory leukemia. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  U. Haberkorn,et al.  A new precursor for the radiosynthesis of [18F]FLT. , 2002, Nuclear medicine and biology.

[15]  I. Kocić.  Clevudine University of Georgia/Abbott/Bukwang/Triangle/Yale University. , 2000, Current opinion in investigational drugs.

[16]  J. Bading,et al.  Pharmacokinetics of the thymidine analog 2'-fluoro-5-[(14)C]-methyl-1-beta-D-arabinofuranosyluracil ([(14)C]FMAU) in rat prostate tumor cells. , 2000, Nuclear medicine and biology.

[17]  A. Shields,et al.  Radiosynthesis of 3'-deoxy-3'-[(18)F]fluorothymidine: [(18)F]FLT for imaging of cellular proliferation in vivo. , 2000, Nuclear medicine and biology.

[18]  Shwu-Huey Liu,et al.  Unique Metabolism of a Novel Antivirall-Nucleoside Analog, 2′-Fluoro-5-Methyl-β-l-Arabinofuranosyluracil: a Substrate for Both Thymidine Kinase and Deoxycytidine Kinase , 1998, Antimicrobial Agents and Chemotherapy.

[19]  Y. L. Zhu,et al.  Structure‐Activity Relationships of 1‐(2‐Deoxy‐2‐fluoro‐β‐L‐ arabinofuranosyl)pyrimidine Nucleosides as anti‐Hepatitis B Virus Agents. , 1996 .

[20]  R. Mulligan,et al.  A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[21]  Y. L. Zhu,et al.  Structure--activity relationships of 1-(2-Deoxy-2-fluoro-beta-L-arabinofuranosyl)pyrimidine nucleosides as anti-hepatitis B virus agents. , 1996, Journal of medicinal chemistry.

[22]  Y. L. Zhu,et al.  Inhibition of hepatitis B virus by a novel L-nucleoside, 2'-fluoro-5-methyl-beta-L-arabinofuranosyl uracil , 1996, Antimicrobial agents and chemotherapy.

[23]  C. K. Chu,et al.  Pharmacokinetics of 1 -(2-Deoxy-2-fluoro-β-L-arabino-furanosyl)-5-methyluracil (L-FMAU) in Rats , 1995, Pharmaceutical Research.

[24]  P. Conti,et al.  Synthesis of 2'-fluoro-5-[11C]-methyl-1-beta-D-arabinofuranosyluracil ([11C]-FMAU): a potential nucleoside analog for in vivo study of cellular proliferation with PET. , 1995, Nuclear medicine and biology.

[25]  Y. Cheng,et al.  Use of 2'-fluoro-5-methyl-beta-L-arabinofuranosyluracil as a novel antiviral agent for hepatitis B virus and Epstein-Barr virus , 1995, Antimicrobial agents and chemotherapy.

[26]  D. Wong,et al.  High performance liquid chromatography of carbon-11 labeled thymidine and its major catabolites for clinical PET studies. , 1994, Nuclear medicine and biology.

[27]  T. Borght,et al.  Brain tumor imaging with PET and 2-[carbon-11]thymidine. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[28]  L G Strauss,et al.  The applications of PET in clinical oncology. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[29]  J Grierson,et al.  Utilization of labeled thymidine in DNA synthesis: studies for PET. , 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[30]  P. Martiat,et al.  In vivo measurement of carbon-11 thymidine uptake in non-Hodgkin's lymphoma using positron emission tomography. , 1988, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[31]  J. Sherley,et al.  Regulation of human thymidine kinase during the cell cycle. , 1988, The Journal of biological chemistry.

[32]  H. G. Howell,et al.  Fluorocarbohydrates in synthesis. An efficient synthesis of 1-(2-deoxy-2-fluoro-.beta.-D-arabinofuranosyl)-5-iodouracil (.beta.-FIAU) and 1-(2-deoxy-2-fluoro-.beta.-D-arabinofuranosyl)thymine (.beta.-FMAU) , 1985 .

[33]  K. Watanabe,et al.  NUCLEOSIDES. 129. SYNTHESIS OF ANTIVIRAL NUCLEOSIDES: 5-ALKENYL-1-(2-DEOXY-2-FLUORO-β-D-ARABINOFURANOSYL)URACILS , 1984 .

[34]  T. Chou,et al.  Distribution, Metabolism, and Excretion of 1-(2-Fluoro-2-deoxy-β-d-arabinofuranosyl)thymine and 1-(2-Fluoro-2-deoxy-β-d-arabinofuranosyl)-5-iodocytosine , 1983 .

[35]  C S Patlak,et al.  Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data , 1983, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[36]  Kyoichi A. Watanabe,et al.  NUCLEOSIDES. 110. SYNTHESIS AND ANTIHERPES VIRUS ACTIVITY OF SOME 2′-FLUORO-2′-DEOXYARABINOFURANOSYLPYRIMIDINE NUCLEOSIDES , 1979 .

[37]  A. Wolf,et al.  Detection of DNA synthesis in intact organisms with positron-emitting (methyl- 11 C)thymidine. , 1972, Proceedings of the National Academy of Sciences of the United States of America.

[38]  유병철,et al.  Rapid Quantitative Determination of L-FMAU-TP from Human Peripheral-Blood Mononuclear Cells of Hepatitis B Virus-Infected Patients Treated with L-FMAU by Ion-Pairing, Reverse-Phase, Liquid Chromatography/Electrospray Tandem Mass Spectrometry , 2006 .

[39]  Karen Engel,et al.  Mammalian nucleoside transporters. , 2004, Current drug metabolism.

[40]  O. Muzik,et al.  Imaging DNA synthesis with [18F]FMAU and positron emission tomography in patients with cancer , 2004, European Journal of Nuclear Medicine and Molecular Imaging.

[41]  M. Buti,et al.  Entecavir, FTC, L-FMAU, LdT and others. , 2003, Journal of hepatology.

[42]  Y. Cheng,et al.  Preclinical investigation of L-FMAU as an anti-hepatitis B virus agent. , 1998, Antiviral therapy.

[43]  F. Kridelka,et al.  Stereotaxic needle-core biopsy and fine-needle aspiration biopsy in the diagnosis of nonpalpable breast lesions: controversies and future prospects. , 1997, European journal of radiology.

[44]  C. K. Chu,et al.  Pharmacokinetics of 1-(2-deoxy-2-fluoro-beta-L-arabinofuranosyl)-5-methyluracil (L-FMAU) in rats. , 1995, Pharmaceutical research.

[45]  K. Watanabe,et al.  Nucleosides. 129. Synthesis of antiviral nucleosides: 5-alkenyl-1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)uracils. , 1984, Journal of medicinal chemistry.